Your browser doesn't support javascript.
loading
One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life.
Henry, Ouzama; Brzostek, Jerzy; Czajka, Hanna; Leviniene, Giedra; Reshetko, Olga; Gasparini, Roberto; Pazdiora, Petr; Plesca, Doina; Desole, Maria Giuseppina; Kevalas, Rimantas; Gabutti, Giovanni; Povey, Michael; Innis, Bruce.
Afiliação
  • Henry O; Vaccine Discovery and Development, GSK, Philadelphia, United States. Electronic address: ouzama.n.henry@gsk.com.
  • Brzostek J; Poradnia Chorób Zakaznych ZOZ Debica, Debica, Poland. Electronic address: jerzy_br@poczta.onet.pl.
  • Czajka H; Infectious Diseases Outpatient Clinic, The St. Luis Provincial Specialist Children's Hospital, Cracow, Poland. Electronic address: hanna.czajka@onet.pl.
  • Leviniene G; Pediatric Clinic, Lithuanian University of Health Sciences, Kaunas, Lithuania. Electronic address: giedralev@gmail.com.
  • Reshetko O; Pharmacology, Saratov Medical University, Saratov, Russia. Electronic address: reshetko@yandex.ru.
  • Gasparini R; Department of Health Sciences, Genoa University, Genoa, Italy. Electronic address: gasparini@unige.it.
  • Pazdiora P; Department of Epidemiology, Medical Faculty Pilsen of Charles University, Czech Republic. Electronic address: PAZDIORA@fnplzen.cz.
  • Plesca D; Pediatrics, University of Medicine and Pharmacy, Bucharest, Romania. Electronic address: doinaplesca@yahoo.com.
  • Desole MG; Servizio di Igiene Pubblica, ASL Sassari, Italy. Electronic address: madesole@aslsassari.it.
  • Kevalas R; Pediatric Clinic, Lithuanian University of Health Sciences, Kaunas, Lithuania. Electronic address: rimantas.kevalas@kaunoklinikos.lt.
  • Gabutti G; Department of Medical Sciences, University of Ferrara, Ferrara, Italy. Electronic address: giovanni.gabutti@unife.it.
  • Povey M; Biostatistics, GSK, Wavre, Belgium. Electronic address: michael.x.povey@gsk.com.
  • Innis B; Vaccine Discovery and Development, GSK, Philadelphia, United States. Electronic address: innisb00@gmail.com.
Vaccine ; 36(3): 381-387, 2018 01 08.
Article em En | MEDLINE | ID: mdl-29224964
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Varicela / Esquemas de Imunização / Vacina contra Varicela / Anticorpos Antivirais Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Female / Humans / Infant / Male País/Região como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Varicela / Esquemas de Imunização / Vacina contra Varicela / Anticorpos Antivirais Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Female / Humans / Infant / Male País/Região como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article